These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2302 related items for PubMed ID: 15922506
1. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A. Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506 [Abstract] [Full Text] [Related]
2. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H. Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598 [Abstract] [Full Text] [Related]
3. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial. Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Greenspan A. Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159 [Abstract] [Full Text] [Related]
6. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses. Mintzer JE, Tune LE, Breder CD, Swanink R, Marcus RN, McQuade RD, Forbes A. Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864 [Abstract] [Full Text] [Related]
7. Risperidone for the treatment of behavioral and psychological symptoms of dementia. Tune LE. J Clin Psychiatry; 2001 Nov; 62 Suppl 21():29-32. PubMed ID: 11584986 [Abstract] [Full Text] [Related]
8. A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease. Streim JE, Porsteinsson AP, Breder CD, Swanink R, Marcus R, McQuade R, Carson WH. Am J Geriatr Psychiatry; 2008 Jul; 16(7):537-50. PubMed ID: 18591574 [Abstract] [Full Text] [Related]
9. The effect of risperidone on nursing burden associated with caring for patients with dementia. Frank L, Kleinman L, Ciesla G, Rupnow MF, Brodaty H. J Am Geriatr Soc; 2004 Sep; 52(9):1449-55. PubMed ID: 15341545 [Abstract] [Full Text] [Related]
12. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia. Suh GH, Greenspan AJ, Choi SK. Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257 [Abstract] [Full Text] [Related]
13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [Abstract] [Full Text] [Related]
14. Mortality in elderly dementia patients treated with risperidone. Haupt M, Cruz-Jentoft A, Jeste D. J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812 [Abstract] [Full Text] [Related]
18. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F. Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353 [Abstract] [Full Text] [Related]
20. [Risperidone in the treatment of psychotic, affective and behavioral symptoms associated to Alzheimer's disease]. Barcia D, Giles E, Herraiz M, Moríñigo A, Roca M, Rodríguez A. Actas Esp Psiquiatr; 1999 Nov; 27(3):185-90. PubMed ID: 10431061 [Abstract] [Full Text] [Related] Page: [Next] [New Search]